---
figid: PMC6204952__gutjnl-2018-316029f04
figtitle: GC-C activation, intracellular effects
organisms:
- NA
pmcid: PMC6204952
filename: gutjnl-2018-316029f04.jpg
figlink: /pmc/articles/PMC6204952/figure/F4/
number: F4
caption: GC-C activation, intracellular effects. (A) The GC-C receptor is activated
  by both endogenous and exogenous ligands, which increase intracellular cGMP levels.
  The subsequent regulation of protein kinases, phosphodiesterases and ion channels
  modulates a number of downstream physiological mechanisms including fluid and electrolyte
  secretion, barrier function, inflammation and proliferation. (B) Dysregulation of
  this signalling pathway in turn produces epithelial dysfunction, which may contribute
  to chronic constipation, IBDs and intestinal tumourigenesis. CFTR, cystic fibrosis
  transmembrane conductance regulator; GC-C, guanylate cyclase-C; GTP, guanosine triphosphate;
  MLCK, myosin light chain kinase; PDE3, phosphodiesterase 3; NHE3, Na+/H+ exchanger-3;
  PKA, protein kinase A; PKG II, protein kinase G II; TJP, tight junction protein;
  TNFα, tumour necrosis factor alpha.
papertitle: Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders.
reftext: Scott A Waldman, et al. Gut. 2018 Aug;67(8):1543-1552.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9541692
figid_alias: PMC6204952__F4
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6204952__F4
ndex: 99d9e0f2-deae-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6204952__gutjnl-2018-316029f04.html
  '@type': Dataset
  description: GC-C activation, intracellular effects. (A) The GC-C receptor is activated
    by both endogenous and exogenous ligands, which increase intracellular cGMP levels.
    The subsequent regulation of protein kinases, phosphodiesterases and ion channels
    modulates a number of downstream physiological mechanisms including fluid and
    electrolyte secretion, barrier function, inflammation and proliferation. (B) Dysregulation
    of this signalling pathway in turn produces epithelial dysfunction, which may
    contribute to chronic constipation, IBDs and intestinal tumourigenesis. CFTR, cystic
    fibrosis transmembrane conductance regulator; GC-C, guanylate cyclase-C; GTP,
    guanosine triphosphate; MLCK, myosin light chain kinase; PDE3, phosphodiesterase
    3; NHE3, Na+/H+ exchanger-3; PKA, protein kinase A; PKG II, protein kinase G II;
    TJP, tight junction protein; TNFα, tumour necrosis factor alpha.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - na
  - Cftr
  - Nhe3
  - Pkg21D
  - egr
  - ca
  - for
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Akt
  - Strn-Mlck
  - CycE
  - cyc
  - LanB2
  - anon-70Db
  - gs
  - ci
  - PSMA2
  - CYCSP24
  - GUCY2C
  - CFTR
  - SLC9A3
  - TNF
  - IFNG
  - IL1B
  - BRD2
  - PRKG1
  - PRKG2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - F11R
  - PDE3A
  - PDE3B
  - AKT1
  - AKT2
  - AKT3
  - MYLK
  - MYLK2
  - MYLK3
  - GNAS
  - GNAL
  - Na
---
